Abstract |
Though ginsenoside metabolite compound K was known to have antitumor effect in several cancers, its underlying apoptotic mechanism still remains unclear so far. Thus, in the present study, the apoptotic mechanism of compound K was explored in colorectal cancer cells ( CRCs) in association with leucine rich repeat containing G protein-coupled receptor 5 (LGR5) that was overexpressed in colorectal cancers with poor survival rate. Here compound K significantly reduced viability of HCT116p53+/+ cells better than that of HCT116p53-/- cells. Consistently, compound K increased sub G1 population and attenuated the expression of LGR5, c-Myc, procaspase3, Pin1 in HCT116p53+/+ cells more than in HCT116p53-/- cells. Conversely, caspase 3 inhibitor Z-DEVD-FMK reversed inhibitory effect of compound K on LGR5, c-Myc and procaspase3 in HCT116 cells. Consistently, inhibition of LGR5 using transfection method enhanced suppression of pro-PARP, Bcl-xL c-Myc, Snail and Pin1 in compound K treated HCT116p53+/+ cells. Furthermore, compound K synergistically potentiated antitumor effect of 5-fluorouracil (5-FU) or Doxorubicin to reduce the survival genes and cytotoxicity in HCT116p53+/+ cells. Overall, our findings provide scientific insight that compound K induces apoptosis in colon cancer cells via caspase and p53 dependent LGR5 inhibition with combination therapy potential with 5-FU or doxorubicin.
|
Authors | Ji-Na Pak, Ji Hoon Jung, Ji Eon Park, Jisung Hwang, Hyo Jung Lee, Bum-Sang Shim, Sung-Hoon Kim |
Journal | Phytotherapy research : PTR
(Phytother Res)
Vol. 34
Issue 10
Pg. 2745-2755
(Oct 2020)
ISSN: 1099-1573 [Electronic] England |
PMID | 32403193
(Publication Type: Journal Article)
|
Copyright | © 2020 John Wiley & Sons, Ltd. |
Chemical References |
- Ginsenosides
- LGR5 protein, human
- Receptors, G-Protein-Coupled
- Tumor Suppressor Protein p53
- ginsenoside M1
- CASP3 protein, human
- Caspase 3
|
Topics |
- Apoptosis
- Caspase 3
(metabolism)
- Cell Line, Tumor
- Colorectal Neoplasms
(genetics, pathology)
- Ginsenosides
(pharmacology, therapeutic use)
- HCT116 Cells
(metabolism)
- Humans
- Receptors, G-Protein-Coupled
(antagonists & inhibitors)
- Tumor Suppressor Protein p53
(metabolism)
|